Karen Brown
General Counsel at PRIME MEDICINE, INC.
Profile
Karen Brown is a professional with experience in intellectual property and legal affairs.
She is currently a Senior VP at Prime Medicine, Inc. Previously, she worked as the Chief Intellectual Property Counsel at Ironwood Pharmaceuticals, Inc. and as the Senior Vice President of IP & Legal Affairs at Obsidian Therapeutics, Inc. Brown holds a doctorate from Boston University, an undergraduate degree from Princeton University, and a graduate degree from Fordham University School of Law.
Karen Brown active positions
| Companies | Position | Start |
|---|---|---|
| PRIME MEDICINE, INC. | General Counsel | - |
Former positions of Karen Brown
| Companies | Position | End |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | General Counsel | - |
Training of Karen Brown
| Princeton University | Undergraduate Degree |
| Boston University | Doctorate Degree |
| Fordham University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PRIME MEDICINE, INC. | Health Technology |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Karen Brown
